🟡 Medium ImpactPharma
Glenmark Pharma launches Methylene Blue injection in USA
Glenmark Pharmaceuticals launched Methylene Blue Injection USP, 50 mg/10 mL in the US market. The product is indicated for the treatment of acquired methemoglobinemia. Launch expands Glenmark’s presence in the US generics segment. 📊 STOCKS: GLENMARK | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Launch
#Launch#USMarket#Glenmark
Stocks mentioned
⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.
Trade smarter on NSE
Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.
Start for ₹1 →